Jf. Desassis et al., Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre, NEPH DIAL T, 14(11), 1999, pp. 2692-2697
Background. Previous studies, detecting GB virus-C (GBV-C) or hepatitis G v
irus (HGV) RNA by using reverse transcriptase polymerase chain reaction (RT
-PCR), have shown that haemodialysis (HD) patients had a high risk of being
infected and viraemic with this virus. A past GBV-C/HGV contact can now be
detected by testing for antibodies directed against the GBV-C/HGV envelope
protein E2 (anti-E2).
Methods. In order to evaluate GBV-C/HGV contact, 120 patients undergoing ch
ronic HD were tested for GBV-C:HGV RNA by RT-PCR and anti-E2 antibodies by
ELISA. GBV-C/HGV viraemic patients were followed prospectively for 18 month
s, and retrospectively when sera were stored. The total follow-up was betwe
en 18 and 78 months.
Results. GBV-C/HGV RNA was detected in 17 patients( 14%), and 18 patients(1
5%) had a significant level of anti-E2 antibodies. No positive anti-E2 spec
imens were also positive for GBV-C/HGV RNA and vice versa. A total of 35 pa
tients (29%) were contaminated with GBV-C/HGV. Sixteen of the 17 viraemic p
atients had a persistent viraemia (follow-up 18-78 months) and one cleared
the virus during the study period. A past or present GBV-C/HGV contact was
statistically correlated with the duration of HD and hepatitis C virus(HCV)
infection, but was independent of age, hepatitis B virus (HBV) infection,
and alanine aminotransferase (ALT) level.
Conclusions. Twenty-nine per cent of patients who underwent HD in our centr
e have been infected by GBV-C/HGV, 49% were still viraemic and 51% have dev
eloped anti-E2 antibodies, indicating a past contact with GBV-C/HGV. Our re
sults demonstrate that the prevalence of GBV-C/HGV contact in HD was undere
stimated when only RT-PCR was used. Therefore GBV-C/HGV contact is probably
much more frequent in HD than previous studies would suggest and is at thi
s time not correlated with hepatotoxicity. Anti-HCV antibodies blood screen
ing since 1990 and recent changes in managing HD patients have probably red
uced GBV-C/HGV contact in the same way.